1625 related articles for article (PubMed ID: 26710111)
41. "Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrP
Qin K; Zhao L; Gregory C; Solanki A; Mastrianni JA
Sci Rep; 2019 Jun; 9(1):8524. PubMed ID: 31189938
[TBL] [Abstract][Full Text] [Related]
42. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
43. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
44. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
45. Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.
Nieznanski K; Choi JK; Chen S; Surewicz K; Surewicz WK
J Biol Chem; 2012 Sep; 287(40):33104-8. PubMed ID: 22915585
[TBL] [Abstract][Full Text] [Related]
46. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
[TBL] [Abstract][Full Text] [Related]
47. Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity.
Cortijo-Arellano M; Ponce J; Durany N; Cladera J
Biochem Biophys Res Commun; 2008 Apr; 368(2):238-42. PubMed ID: 18206983
[TBL] [Abstract][Full Text] [Related]
48. Single-molecule imaging reveals that small amyloid-β1-42 oligomers interact with the cellular prion protein (PrP(C)).
Ganzinger KA; Narayan P; Qamar SS; Weimann L; Ranasinghe RT; Aguzzi A; Dobson CM; McColl J; St George-Hyslop P; Klenerman D
Chembiochem; 2014 Nov; 15(17):2515-21. PubMed ID: 25294384
[TBL] [Abstract][Full Text] [Related]
49. Prion protein in exosomes: partnering Aβ peptides and driving fibrilization.
Martins VR; Prado MA
J Neurochem; 2016 Apr; 137(1):9-11. PubMed ID: 26935988
[No Abstract] [Full Text] [Related]
50. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
51. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
[TBL] [Abstract][Full Text] [Related]
52. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
53. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
54. Prion protein (PrPc) promotes beta-amyloid plaque formation.
Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
[TBL] [Abstract][Full Text] [Related]
55. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.
Sempou E; Biasini E; Pinzón-Olejua A; Harris DA; Málaga-Trillo E
Mol Neurodegener; 2016 Feb; 11():18. PubMed ID: 26860872
[TBL] [Abstract][Full Text] [Related]
56. Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles.
Joshi P; Turola E; Ruiz A; Bergami A; Libera DD; Benussi L; Giussani P; Magnani G; Comi G; Legname G; Ghidoni R; Furlan R; Matteoli M; Verderio C
Cell Death Differ; 2014 Apr; 21(4):582-93. PubMed ID: 24336048
[TBL] [Abstract][Full Text] [Related]
57. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
[TBL] [Abstract][Full Text] [Related]
58. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
[TBL] [Abstract][Full Text] [Related]
59. Development of Alkaline Phosphatase-Fused Mouse Prion Protein and Its Application in Toxic Aβ Oligomer Detection.
Tsukakoshi K; Kubo R; Ikebukuro K
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498917
[TBL] [Abstract][Full Text] [Related]
60. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
Nygaard HB; Strittmatter SM
Arch Neurol; 2009 Nov; 66(11):1325-8. PubMed ID: 19901162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
